Subscribe to CGD’s weekly newsletter below, and watch for an email with the option to receive more of what interests you.

(if not affiliated type "individuals")
Already subscribed? Please click “manage subscriptions” on any email from Center for Global Development (cgd@email.cgdev.org) to update your preferences.

Tag: Global Health


The Importance of Global Health Investment

Blog Post

One of the things I am proudest of having done in Washington was having the idea as Chief Economist of the World Bank that the Bank should devote its annual World Development Report to making the case for improving both the quantity and quality of global health investment.

The 5000% Price Increase and the Economic Case for Pharma Price Regulation

Blog Post

You’ve probably already heard about the pharma outrage du jour. In short: start-up Turing Pharmaceuticals, led by combative ex-hedge fund manager Martin Shkreli, recently acquired Daraprim, a 60+ year-old drug to treat a parasitic infection called toxoplasmosis – the only available treatment for this rare infection – which can become deadly for HIV+ individuals and others with weakened immune systems. Turing then promptly raised the price by more than 5000%, from $13.50 to $750 per tablet, such that a single individual’s treatment can now cost up to $634,000.

The World Bank Keeps Missing Opportunities to Save Lives and Mobilize Domestic Revenues

Blog Post

I have argued that tobacco taxes are the single best health policy that any country could implement. The World Bank is the most prominent organization in the world with the skills, mandate, and network to support raising tobacco taxes in developing countries where the number of smokers and shortened lives is increasing every year. Yet, the World Bank has committed far too little to this effort. One of the key reasons is that World Bank management has let this best-buy for development fall between the cracks – tobacco is a health issue and taxes are a fiscal policy issue.

An Insider’s Perspective on Delivering a DIB

Blog Post

No one said creating development impact bonds (DIB) was going to be easy, but that hasn’t stopped the development community from trying to get them off the ground. The Fred Hollows Foundation, based in Australia, has been hard at work on a DIB to address cataract blindness in Africa. As the Foundation attracts partners to help fund and implement a pilot of the cataract bond, Dr. Lachlan McDonald, the Foundation’s senior health economist, and Alex Rankin, their Global Lead for Policy, Advocacy & Research, shared some lessons learned so far. With Lachlan and Alex’s permission, we’re turning some of those lessons over to you – we hope they’re useful to others seeking to move ahead with their own DIB.

Doing Good Is No Place for Emotion – Podcast with Will MacAskill

Blog Post

When the next natural disaster strikes, Will MacAskill does not want you to donate to the relief effort. And if a relative dies from a disease, he doesn’t think you should try and raise money for that cause. Rather, he wants you to focus on the "ongoing disasters" that sicken, maim and kill thousands of people every day, mostly in the developing world.

You Ask, We Answer: What Would US Global Health Reform Really Look Like?

Blog Post

As we gear up for the 2016 election, we’re thinking critically about how the next US president can increase the impact and efficiency of America’s taxpayer-funded global health investments. The US lacks a government-wide strategy on global health engagement, and it shows—most recently in the slow and messy response to the Ebola crisis. But we think it doesn’t have to be this way.

In Health Spending, Middle-Income Countries Face a Priorities Ditch, Not a Financing Ditch – But That Still Merits Aid

Blog Post

After a successful replenishment earlier this year, the board of Gavi, the Vaccine Alliance, is thinking through how to maximize the impact of the money it has raised. One hot issue is graduation from Gavi support. Currently, the Alliance uses an income cutoff loosely based on eligibility for IDA — soft loans from the World Bank. 


By Date